Related Experiment Video

Updated: Jun 2, 2026

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

The effect of recurrent severe hypoglycemia on cognitive performance in children with type 1 diabetes: a

Annalisa Blasetti1, Rosa Maria Chiuri, Anna Maria Tocco

  • 1Department of Pediatrics, University of Chieti, Chieti, Italy. ablasetti@tiscalinet.it

Journal of Child Neurology
|May 17, 2011
PubMed

Insights

Recurrent severe hypoglycemia in children with type 1 diabetes may impact cognitive functions like memory and learning. Further research is needed due to study limitations.

Area of Science:

  • Pediatric Endocrinology
  • Neuropsychology
  • Metabolic Disorders

Background:

  • Type 1 diabetes (T1D) management involves balancing glycemic control with the risk of severe hypoglycemia.
  • Severe hypoglycemia episodes in children with T1D may pose risks to developing cognitive functions.

Purpose of the Study:

  • To investigate cognitive impairment in children with T1D experiencing recurrent severe hypoglycemia.
  • To synthesize existing research using meta-analysis to determine the extent of cognitive deficits.

Main Methods:

  • Meta-analysis of studies involving children with T1D.
  • Comparison of cognitive performance between children with and without recurrent severe hypoglycemia.
  • Inclusion of 441 children with recurrent severe hypoglycemia and 560 controls.

Main Results:

  • Children with T1D and recurrent severe hypoglycemia showed slightly lower performance in intelligence, memory, learning, and verbal fluency.
  • Cognitive impairment was most pronounced in memory and learning domains.
  • No significant impairment was observed in motor speed.

Conclusions:

  • Recurrent severe hypoglycemia appears to have a selective negative effect on specific cognitive functions in children with T1D.
  • Findings should be interpreted cautiously due to small sample sizes, varied definitions of severe hypoglycemia, and diverse neuropsychological tests used.

More Related Videos

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

Related Concept Videos

Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.